Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 632 participants.
Also called NCT07180472
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 632 participants
- Registry
-
NCT07180472
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07180472. Randomized; no masking; primary purpose treatment. Start 2025-09-20 (anticipated); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol
- Condition
- Cerebral Small Vessel Disease
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- First Affiliated Hospital of Chengdu Medical College
Record details
- Record id
cardio:ct-nct07180472- Content hash
09fd1a77fcf65d8cb9e8155033c575705079a99bb051baf6e6d205c2027684a9